BioAtla, Inc. Common Stock (BCAB) is a publicly traded Healthcare sector company. As of May 21, 2026, BCAB trades at $3.44 with a market cap of $6.50M and a P/E ratio of -0.73. BCAB moved -3.36% today. Year to date, BCAB is -82.97%; over the trailing twelve months it is -81.51%. Its 52-week range spans $3.26 to $126.25. Rallies surfaces BCAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
BioAtla, Inc. Common Stock (BCAB) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BCAB moved -3.36% today.
| Metric | Value |
|---|---|
| Price | $3.44 |
| Market Cap | $6.50M |
| P/E Ratio | -0.73 |
| EPS | $-4.97 |
| Dividend Yield | 0.00% |
| 52-Week High | $126.25 |
| 52-Week Low | $3.26 |
| Volume | 28.74K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.00M |
| Net Income | $-50.62M |
| Gross Margin | 0.00% |
BCAB analyst coverage data. Average price target: $0.00.